Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro

Anticancer Research

Volumn 18, Issue 5 A, 1998, Pages 3585-3589

  Knüpfer, Matthias M ^a   Hernáiz Driever, Pablo ^b   Poppenborg, Heike ^a   Wolff, Johannes E A ^c   Cinatl, Jindrich ^d  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

Cell culture; FACS; MTT; N CAM

Indexed keywords

ALKANOIC ACID; CD56 ANTIGEN; HERMES ANTIGEN; VALPROIC ACID;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD44; ANTIGENS, CD56; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CELL DIVISION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOMA; HUMANS; RATS; TUMOR CELLS, CULTURED; VALPROIC ACID;

EID: 0031763892     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K: Correlates of survival and Daumas-Duport grading system for astrocytomas. J Neurosurg 74: 27-37, 1991.
2. Packer RJ, Boyett JM, Zimmermann RA, Albright AL, Kaplan AM, Rorke LB, Selch MT, Cherlow JM, Finlay JL, Wara WM: Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. Cancer 74: 1827-1834, 1994.
3. Samid D, Shack S, Sherman LT: Phenylacetate: a novel non-toxic inducer of tumor cell differentiation. Cancer Res 52: 1988-1992, 1992.
4. Miller AA, Kurschel E, Osieka R, Schmidt CG: Clinical pharmacology of sodium butyrate in patients with acute luekemia. Eur J Cancer Clin Oncol 23: 1283-1287, 1987.
5. Prasanna P, Thibault A, Liu L, Samid D: Lipid metabolism as a target for brain cancer therapy: synergistic acticity of lovastatin and sodium phenylacetate against human glioma cells. J Neurochem 66: 710-716, 1996.
6. Stockhammer G, Manley GT, Johnson R, Rosenblum MK, Samid D, Liebermann FS: Inhibition of proliferation and induction of differentiation in medulloblastoma- and astrocytoma-derived cell lines with phenylacetate. J Neurosurg 83: 672-681, 1995.
7. Thibault A, Cooper MR, Figg WD: A phase I and pharmacokinetics study of intravenous phenylacetate in patients with cancer. Cancer Res 54: 1690-1694, 1994.
8. Chapman A, Keane PE, Meldrum BS, Simiand J, Vernieres JC: Mechanism of anticonvulsant action of valproate. Progress Neurobiol 19: 315-359, 1982.
9. Davis R, Peters DH, McTavish D: Valproic acid. A reappraisal of ist pharmacological properties and clinical efficicacy in epilepsy. Drugs 47: 332-372, 1994.
10. Cinatl J Jr, Cinatl J, Scholz M et al: Antitumor activity of sodium valproate in cultures of human neuroblastoma cells. Anti-Cancer Drugs 7: 766-773, 1996.
11. Cinatl J Jr, Cinatl J, Hernaiz-Driever P et al: Valproic acid has antitumoral effects on neuroblastoma xenografts in nude mice. Cancer Letters, in press, 1997.
12. Bilzer T, Stavrou D, Dahme E et al: Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows-Arch-A-Pathol-Anat-Histopathol 418: 281-293, 1991.
13. Stavrou D, Freiberg B, Meyermann R, Anzil AP, Keiditsch E, Mehraein P: Radioimmunodetection of human glioma xenografts by radiolabelled monoclonal antibodies. Anticancer Res 11: 537-542, 1991.
14. Hansen M, Nielsen SE, Berg K: Re-examination and furhter development of a precise and rapid dye method for measure cell growth/cell kill. J Immunol Methods 119: 203-210, 1991.
15. Leon JA, Mesa-Tejada R, Gutierrez MC: Increased surface expression and shedding of tumor associated antigens of human breast cell carcinoma cells treated with recombinant human interferons or phorbol ester tumor promotors. Anticancer Res 9: 1639-1647, 1989.
16. Edvardsen K, Chen W, Rucklidge G, Walsh FS, Obrink B, Bock E: Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored N-CAM, downregu-lates secreation of matrix metalloproteinases. Proc Nat Acad Sci USA 90: 11463-11467, 1993.
17. Edvardsen K, Peddersen PH, Bjerkvig R et al: Transfection of glioma cells with the neural-cell adhesion molecule NCAM: Efffect on glioma cell invasion and growth in vivo. Int J Cancer 58: 116-122, 1994.
18. Fantini J, Guo XJ, Marvaldi J, Rougon G: Suramin inhibits proliferation of rat glioma cells and alters N-CAM cell surface expression. Int J Cancer 45: 554-561, 1990.
19. Jaaskelainen J, Maenpaa A, Patarroyo M et al: Migration of recombinant IL-2 activated T and natural killer cells in the intercellular space of human H-2 glioma spheroids in vitro. A study on adhesion molecules involved. J Immunol 149: 260-268, 1992.
20. Nitta T, Yagita H, Sato K, Okumura K: Involvement of CD56 (NKH-1/Leu-19 antigen) as an adhesion molecule in natural killer-target cell interaction. J Exp Med 170: 1757-1761, 1989.
21. Merzak A, Koocheckpour S, Pilkington GJ: CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54(15): 3988-92, 1994.
22. Ariza A, Lopez D, Mate JL et al: Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study. Hum Pathol 26(10): 1144-7, 1995.
23. Sakai H, Nakashima S, Yoshimura S, Nakatani K, Shinoda J, Sakai N, Yamada H, Nozawa Y: Suppressed expression of CD44 variant isoforms during human glioma cell differentiation induced by cyclic AMP. Neurosci Lett 270: 189-192, 1996.
24. Okada H, Yoshida J, Sokabe M, Wakabayashi T, Hagiwara M: Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer 66: 255-260, 1996.
25. Smith S and Stern A: The effect of aromatic CoA esters on fatty acid synthetase: biosynthesis of w-phenyl fatty acids. Arch Biochem Biophys 222: 259-265, 1983.
26. Samid D, Ram Z, Hudgins WR: Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res 54: 891-895, 1994.
27. Boffa LC, Mariani MR, Parker MI: Selective hypermethylation of transcribed nucleosomal DNA by sodium butyrate. Exp Cell Res 218: 420-423, 1994.